Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 15 of 15 results for tendinopathy

  1. Autologous blood injection for tendinopathy (HTG299)

    Evidence-based recommendations on autologous blood injection for tendinopathy. This involves supplying the tendon with growth factors that start the healing process.

    HealthTech guidance
    Published
    23 January 2013
    View recommendations

    Sections for HTG299

  2. Extracorporeal shockwave therapy for Achilles tendinopathy (HTG426)

    Evidence-based recommendations on extracorporeal shockwave therapy for treating Achilles tendinopathy in adults. This involves passing shockwaves through the skin to the affected area.

    HealthTech guidance
    Published
    21 December 2016
    View recommendations

    Sections for HTG426

  3. Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder (HTG645)

    Evidence-based recommendations on extracorporeal shockwave therapy for calcific tendinopathy in the shoulder. This involves placing a device on the skin that delivers short pulses of sound into the shoulder. The aim is to reduce pain and improve shoulder function.

    HealthTech guidance
    Published
    9 November 2022
    View recommendations

    Sections for HTG645

  4. NICE encourages further research comparing autologous blood injections (with or without techniques to produce platelet-rich plasma) against established nonsurgical methods for managing tendinopathy. Trials should clearly describe patient selection (including the site of tendinopathy, duration of symptoms and any prior treatments) and document whether a 'dry needling' technique is used. Outcomes should include specific measures of pain, quality of life and function, and whether subsequent surgical intervention is needed.

    nonsurgical methods for managing tendinopathy. Trials should clearly describe patient selection (including the site of...

    Research recommendation
    Published
    9 June 2015

  5. NICE encourages further research into extracorporeal shockwave therapy (ESWT) for Achilles tendinopathy, which may include comparative data collection. Studies should clearly describe patient selection, treatment protocols, use of local anaesthesia and the type and duration of energy applied (see section 3). Studies should include validated outcome measures and have a minimum of 1 year of follow-up. NICE may update the guidance on publication of further evidence.

    further research into extracorporeal shockwave therapy (ESWT) for Achilles tendinopathy, which may include comparative data collection....

    Research recommendation
    Published
    14 February 2017

  6. Extracorporeal shockwave therapy for refractory tennis elbow (HTG201)

    Evidence-based recommendations on extracorporeal shockwave therapy for refractory tennis elbow. This involves using a machine to deliver sound waves to the painful area to stimulate healing.

    HealthTech guidance
    Published
    26 August 2009
    View recommendations

    Sections for HTG201

  7. Extracorporeal shockwave therapy for refractory plantar fasciitis (HTG200)

    Evidence-based recommendations on extracorporeal shockwave therapy for refractory plantar fasciitis. This involves using a machine to deliver sound waves to the painful area, with the aim to stimulate healing of the fascia.

    HealthTech guidance
    Published
    26 August 2009
    View recommendations

    Sections for HTG200

  8. Evidence on the safety of extracorporeal shockwave therapy for calcific tendinopathy in the shoulder shows no major safety concerns in the short term. Evidence on efficacy is inadequate. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page

    Evidence on the safety of extracorporeal shockwave therapy for calcific tendinopathy in the shoulder shows no major safety concerns in...

    Research recommendation
    Published
    12 December 2022

  9. Autologous blood injection for tendinopathy (IPG438)

    Interventional procedures, IPG438 - Issued: January 2013 --> We have moved interventional procedures guidance 438 to become HealthTech guidance 299. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  10. Autologous blood injection for tendinopathy (IPG279)

    This guidance has been updated and replaced by NICE HealthTech guidance 299.

    Withdrawn guidance

  11. Extracorporeal shockwave therapy for Achilles tendinopathy (IPG571)

    We have moved interventional procedures guidance 571 to become HealthTech guidance 426. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  12. Extracorporeal shockwave therapy for refractory Achilles tendinopathy (IPG312)

    Interventional procedures, IPG312 - Issued: August 2009 --> This guidance has been updated and replaced by NICE interventional procedure guidance 571.

    Withdrawn guidance

  13. Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder (IPG742)

    We have moved interventional procedures guidance 742 to become HealthTech guidance 645. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  14. Extracorporeal shockwave lithotripsy for calcific tendonitis (tendinopathy) of the shoulder (IPG21)

    This guidance has been updated and replaced by NICE interventional procedures guidance 742.

    Withdrawn guidance

  15. Extracorporeal shock wave therapy for refractory tendinopathies (plantar fasciitis and tennis elbow) (IPG139)

    This guidance has been updated and replaced by NICE HealthTech guidance 201.

    Withdrawn guidance